Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial

Reprod Biol Endocrinol. 2021 Oct 12;19(1):158. doi: 10.1186/s12958-021-00836-8.

Abstract

Background: Synchronization of follicles is key to improving ovulation stimulation with the gonadotropin-releasing hormone (GnRH) antagonist protocol. GnRH antagonist administration in the early follicular phase can quickly decrease gonadotrophin (Gn) levels and achieve downregulation before stimulation, which may improves synchronization. A previous small randomized controlled study (RCT) showed that pretreatment with a GnRH antagonist for 3 days before stimulation may increase oocyte retrieval but cannot increase the pregnancy rate. This study investigated whether the GnRH antagonist pretreatment protocol in ovulatory women can increase the synchronization of follicles and pregnancy outcomes compared with the conventional GnRH antagonist protocol.

Methods: This RCT included 136 normal ovulatory women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). Both groups were treated with recombinant follicle-stimulating hormone (r-FSH) and a flexible GnRH antagonist protocol. The women were randomized into two equal groups with or without GnRH antagonist administration from day 2 of the menstrual cycle for 3 days before stimulation. Our primary outcome was the number of retrieved oocytes. Secondary outcomes included the pregnancy rate and live birth rate.

Results: Both groups had similar baseline characteristics. The number of retrieved oocytes in the study group was comparable to that in the control group (9.5 [8.0-13.0] vs. 11.0 [7.0-14.8], P = 0.469). There was no significant difference in the follicle size. The fertilization rate, number of good-quality embryos, implantation rate, pregnancy rate, ongoing pregnancy rate, live birth rate per embryonic transfer cycle, and miscarriage rate were similar between the two groups.

Conclusion: This large RCT analysed GnRH antagonist pretreatment with the GnRH antagonist protocol applied to normal ovulatory women undergoing IVF/ICSI. The number of retrieved oocytes and pregnancy outcomes did not significantly vary.

Trial registration: Chinese Clinical Trial Registry, ChiCTR1800019730 . Registered 26 November 2018.

Keywords: Controlled ovarian stimulation; GnRH antagonist; Pregnancy outcome; Pretreatment; Synchronization.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Abortion, Spontaneous / epidemiology
  • Adult
  • Drug Administration Schedule
  • Female
  • Fertilization in Vitro* / methods
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Hormone Antagonists / administration & dosage*
  • Humans
  • Infant, Newborn
  • Infertility / epidemiology
  • Infertility / therapy
  • Male
  • Ovulation / drug effects
  • Ovulation / physiology
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Outcome / epidemiology
  • Pregnancy Rate
  • Sperm Injections, Intracytoplasmic* / methods

Substances

  • Hormone Antagonists
  • Gonadotropin-Releasing Hormone